“Breaking Down the Numbers: Kyndryl’s Impressive Third Quarter Fiscal Report for 2025”

Kyndryl Consult Reports Strong Financial Results for Q3 2025 Overview Revenues for the quarter ended December 31, 2024, totaled an impressive $3.74 billion for Kyndryl Consult. The company reported a pretax income of $258 million, with a net income of $215 million. Adjusted EBITDA stood at $704 million, while adjusted pretax income and adjusted net…

Read More

AM Best Maintains Stable Outlook on Malaysia’s Non-Life Insurance Segment: A Comprehensive Market Report

Malaysia’s Non-Life Insurance Segment Outlook Solid Premium Growth Expected in Malaysia’s Non-Life Insurance Segment Overview AM Best has maintained its outlook on Malaysia’s non-life insurance segment at stable, citing expectations of solid premium growth and the maintenance of underwriting and pricing discipline maintained amid the phased de-tariffication of motor and fire businesses. The Best’s Market…

Read More

Attention Investors: Don’t Miss Out on Capstone Green Energy Corporation – Get Counsel Before Deadline! (And Why Rosen is the Top Choice)

Rosen Law Firm Reminds Investors of Lead Plaintiff Deadline for Capstone Green Energy Corp. Securities Class Action Lawsuit Important Reminder for Capstone Green Energy Investors Attention all investors of Capstone Green Energy Corp.! The Rosen Law Firm, a top-ranked global investor rights law firm, wants to make sure you are aware of the upcoming deadline…

Read More

“Attention Investors: Pomerantz Law Firm Issues Reminder for Losses on Pacira Biosciences Inc. Investment and Upcoming Deadlines – PCRX Class Action Lawsuit”

Pomerantz LLP Files Class Action Lawsuit Against Pacira Biosciences, Inc. NEW YORK, Feb. 11, 2025 /PRNewswire/ — Pomerantz LLP has announced the filing of a class action lawsuit against Pacira Biosciences, Inc., a pharmaceutical company trading on the NASDAQ under the symbol PCRX. Investors who have been affected by this case are encouraged to contact…

Read More

Yeehaw! Texas Capital Bancshares Inc. Unveils Exciting Third Quarter 2024 Results – Get the Scoop Here!

Record Breaking Quarter for Texas Capital Bancshares, Inc. Quarterly Highlights During the third quarter of 2024, Texas Capital Bancshares, Inc. made significant strategic moves that led to record levels of income in fee areas of focus. These actions included the acquisition of a $332 million commercial loan portfolio and repositioning the proceeds from a $1.2…

Read More